NetCyte Competitive Summary

NetCyte is offering significant distinctive advantages in implementing a Network Access Control (NAC) solution for enterprises enabling the deployment of an effective Bring Your Own Device (BYOD) platform.

The traditional approaches like 802.1x and traffic analysis to network access control, create additional challenges.

Challenges in 802.1X Based Deployments

Existence of network devices not supporting 802.1X.

Existence of network devices not supporting 802.1X.

Highly increased operational workload.

Increased user complaints.

Additional infrastructure investment requirements.

 

Challenges in Traffic Analysis

Increased operational workload, notably for multi-campus networks.

Additional infrastructure investment requirements.

Requirements for changes in the network topology.

Increased cost.

 

With a different approach to network access control, Netcyte is enabling simple discovery by utilising multiple techniques on the network, DNS and application layers providing 100% accurate visibility of network topology. Without an agent, advanced threat analysis and In-depth profiling are performed for the end-points.

The Secure DNS server embedded within our solution enables the discovery of malicious activity without any topology change. The DNS Server acts as the first line of blocking if the device is unauthorized or creates a malicious activity. If the blocked devices reside on a manageable switch/router/firewall blocking takes place at any level by executing a simple VLAN/ACL change through an SSH connection to the network device.

Below is a short competitive analysis between NetCyte and it’s two major competitors Forescout and Cisco ISE.

NetCyte & Cisco ISE Comparison

NetCyte is agentless and does not depend on 802.1X. Cisco ISE is preferred when 802.1X is to be implemented. Advanced compliance checks can only be executed only when an agent is installed in the endpoints.

NetCyte can do advanced threat analytics and weak password discovery without needing an agent or appliance on remote networks. Cisco ISE requires an agent.

NetCyte can track relevant audit data without an agent. Important security events like password changes, account lockouts, event log deletion and group membership changes are recorded, and devices can be blocked if necessary. Cisco ISE does not support such an analysis.

NetCyte does not require a change in the IT infrastructure or configuration change on network devices. Time to implement NetCyte is 4-5 times less compared to Cisco ISE.

NetCyte provides a more detailed set of information collection for Windows-based devices.

NetCyte has support for different methods of discovery and blocking, enabling a simpler implementation of NAC in different scenarios.

NetCyte & Forescout Comparison

NetCyte can do advanced threat analytics and weak password discovery without needing an agent or appliance on remote networks. Forescout does not have this support. Windows-to-Windows remote connections are much more efficient.

NetCyte can track relevant audit data without an agent. Important security events like password changes, account lockouts, event log deletion and group membership changes are recorded, and devices can be blocked if necessary. Forescout does not have this support.

NetCyte agentless operation is more effective and does not create false alarms as it is based on Windows. Windows-to-Windows remote connections are much more efficient.

NetCyte provides a much stronger set of information collection for Windows-based devices.

NetCyte is a next-generation network access control solution that provides dynamic and adaptive access control with unparalleled threat discovery.
DNSCyte is a recursive DNS security service based on global cyber threat intelligence and machine learning to block threats and targeted attacks in real time.
IDCyte is an identity management platform that includes Single Sign On (SSO), Multi-Factor Authentication (MFA) and biometric identity.
Would you like to learn more about how to protect your business?

We're member of 

We're member of

© 2019-2020 CyberCyte. All Rights Reserved.